Sacyr S.A. buy krebskrebs
Start price
17.05.20
/
50%
€1.55
Target price
04.11.21
€1.92
Performance (%)
45.99%
End price
05.11.21
€2.27
Summary
This prediction ended on 05.11.21 with a price of €2.27. With a performance of 45.99% the BUY prediction by krebskrebs was a big success. Dividends of €0.066 are taken into consideration when calculating the performance. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Sacyr S.A. | 1.930% | 1.930% | 7.030% | 56.917% |
iShares Core DAX® | 1.175% | -0.931% | 13.543% | 15.250% |
iShares Nasdaq 100 | 1.232% | 9.715% | 34.899% | 52.433% |
iShares Nikkei 225® | 1.563% | 3.040% | 8.943% | 6.828% |
iShares S&P 500 | 0.034% | 5.962% | 27.285% | 45.090% |
Comments by krebskrebs for this prediction
In the thread Sacyr S.A. diskutieren
Buy mit Kursziel 2,0
In the thread Trading Sacyr S.A.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten